APWM
GCVRZ

Atlas Private Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Atlas Private Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400
Closed – – 514
2019
Q4 		$0 Buy
+400
New +$307 ﹤0.01% 490

Atlas Private Wealth Management's GCVRZ Position: Q1 2020 in Review

Atlas Private Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 400 shares.

Atlas Private Wealth Management first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Atlas Private Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Atlas Private Wealth Management sold 400 Sanofi Contingent Value Rights shares in Q1 2020.
  • Atlas Private Wealth Management first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Atlas Private Wealth Management's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Atlas Private Wealth Management's 13F filing for Q1 2020, filed 12 May 2020.